Sensitivity to first-line chemotherapy for metastatic breast cancer in CHEK2 1100delC mutation carriers is not different compared with sporadic breast cancer patients
Author(s):
Kriege, M.; Jager, A.; Hollestelle, A.; Berns, P.M.J.J.; Sieuwerts, A.M.; Collee, J.M.; Kroep, J.R.; Martens, J.W.M.; Hooning, M.J.; Seynaeve, C.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-03-31
Language
English
Is part of
European Journal of Cancer (2014), Vol. 50, p. S107-S108
